Nicotine patch therapy in smoking cessation reduces the extent of exercise-induced myocardial ischemia

Journal of the American College of Cardiology

Volumn 30, Issue 1, 1997, Pages 125-130

  Mahmarian, John J ^a,b   Moyé, Lemuel A ^a,b   Nasser, George A ^a,c   Nagueh, Sherif F ^a,b   Bloom, Marilyn F ^a   Benowitz, Neal L ^a,d   Verani, Mario S ^a,b   Byrd, William G ^a,e   Pratt, Craig M ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c N Houston Cardiovascular Associates   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE; THALLIUM 201;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; CORONARY RISK; EXERCISE; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HUMAN; MALE; PRIORITY JOURNAL; RISK MANAGEMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SMOKING CESSATION;

ADMINISTRATION, CUTANEOUS; CORONARY DISEASE; EXERCISE TEST; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; NICOTINE; PILOT PROJECTS; PROSPECTIVE STUDIES; SMOKING; SMOKING CESSATION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0030785835     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00128-9     Document Type: Article

References (21)

1. U.S. Department of Health and Human Services. The health consequences of smoking - cardiovascular disease. Washington, DC: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 1983.
2. Benowitz NL. Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med. 319:1988;1318-1330.
3. Fiore MC, Smith SS, Jorenby DE, Baker TB. The effectiveness of the nicotine patch for smoking cessation a meta-analysis . JAMA. 271:1994;1940-1947.
4. Hwang SL. Heart attacks reported in patch users still smoking. Wall Street J June 19, 1992.
5. Food and Drug Administration Drug Advisory Committee Transcript. July 14, 1992.
6. Benowitz NL. Nicotine and coronary heart disease. Trends Cardiovasc Med. 1:1991;315-321.
7. Mahmarian JJ, Pratt CM, Borges-Neto S, Cashion WR, Roberts R, Verani MS. Quantification of infarct size by thallium-201 single-photon emission computed tomography during acute myocardial infarction in man comparison with enzymatic estimates . Circulation. 78:1981;831-839.
8. Mahmarian JJ. Prediction of myocardium at risk clinical significance during acute infarction and in evaluating subsequent prognosis . Cardiol Clin. 13:1995;355-378.
9. Mahmarian JJ, Mahmarian AC, Marks GF, Pratt CM, Verani MS. Role of adenosine thallium-201 tomography for defining long-term risk in patients after acute myocardial infarction. J Am Coll Cardiol. 25:1995;1333-1340.
10. Marie PY, Danchin N, Durand JF, et al. Long-term prediction of major ischemic events by exercise thallium-201 single-photon emission computed tomography incremental prognostic value compared with clinical, exercise testing, catheterization and radionuclide angiographic data . J Am Coll Cardiol. 26:1995;879-886.
11. Iskandrian AS, Chae SC, Heo J, Stanberry CD, Wasserleben V, Cave V. Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease. J Am Coll Cardiol. 22:1993;665-670.
12. Wisconsin Analytical and Research Services. Determination of nicotine and its major metabolite cotinine in human plasma by gas liquid chromatography (WARS-P141.02). Madison (WI): WARS, 1995.
13. Mahmarian JJ, Fenimore NL, Marks GF, et al. Transdermal nitroglycerin patch therapy reduces the extent of exercise-induced myocardial ischemia results of a double-blind, placebo-controlled trial using quantitative thallium-201 tomography . J Am Coll Cardiol. 24:1994;25-32.
14. Mahmarian JJ, Moyé LA, Verani MS, Bloom MF, Pratt CM. High reproducibility of myocardial perfusion defects in patients undergoing serial exercise thallium-201 tomography. Am J Cardiol. 75:1995;1116-1119.
15. Mahmarian JJ, Pratt CM, Cocanaugher MK, Verani MS. Altered myocardial perfusion in patients with angina pectoris or silent ischemia during exercise as assessed by quantitative thallium-201 single-photon emission computed tomography. Circulation. 82:1990;1305-1315.
16. Allred EN, Bleecker ER, Chaitman BR, et al. Short-term effects of carbon monoxide exposure on the exercise performance of subjects with coronary artery disease. N Engl J Med. 321:1989;1426-1432.
17. Adams KF, Koch G, Chatterjee B, et al. Acute elevation of blood carboxyhemoglobin to 6% impairs exercise performance and aggravates symptoms in patients with ischemic heart disease. J Am Coll Cardiol. 12:1988;900-909.
18. Porchet HC, Benowitz NL, Sheiner LB. Pharmacodynamic model of tolerance application to nicotine . J Pharmacol Exp Ther. 244:1988;231-236.
19. 1 the Lung Health Study . JAMA. 272:1994;1497-1505.
20. Gabbay FH, Krantz DS, Kop WJ, et al. Triggers of myocardial ischemia during daily life in patients with coronary artery disease physical and mental activities, anger and smoking . J Am Coll Cardiol. 27:1996;585-592.
21. Deanfield JE, Shea MJ, Wilson RA, Horlock P, de Landsheere CM, Selwyn AP. Direct effects of smoking on the heart silent ischemic disturbances of coronary flow . Am J Cardiol. 57:1986;1005-1009.